Clinical Study Of Fu’s Subcutaneous Needling In The Treatment Of Shoulder-hand Syndrome Phase Ⅰ After Stroke

ObjectiveThe purpose of this study is to observe the clinical efficacy of Fu’ s Subcutaneous Needling(FSN)in the treatment of shoulder-hand syndrome phase I after stroke comparing with Kinetic Needling,and to explore the mechanism of sweeping and reperfusion approach of FSN,for providing theoretical basis for clinical promotion and application of FSN to treat shoulder-hand syndrome phase I after stroke.MethodsIn this clinical study,72 patients suffering from shoulder-hand svndrome phase I after stroke were enrolled in a randomized controlled study.They were divided into FSN group and Kinetic Needling group.During the treatment,4 cases fell off in the FSN group and 5 cases fell off in the Kinetic Needling group,so there were 32 cases in the FSN group and 31 cases in the Kinetic Needling group finally.The loss rates were 11.11%and 13.89%respectively.On the basis of routine medical treatment and rehabilitation training,the FSN group were treated with FSN for pathological tight muscles and combined with reperfusion approach,and the Kinetic Needling group was treated with acupuncture combing with movement.Two groups were treated once every other day,three times a week,for a total of two weeks.The changes of visual analogue score(VAS),swelling score and upper limb simplified Fugl-Meyer motor function score(FMA)were respectively recorded before treatment,once treatment and two-week after treatment,and the clinical efficacy was evaluated after two-week treatment.SPSS 22.0 software was used to analyze and process the data.Results1.VAS score:There was not significant difference in VAS scores between two groups before treatment(P>0.05),indicating that two groups were comparable.The VAS scores of the FSN group after treatment for one time were significantly lower than those before treatment(P<0.01),and the VAS scores of the Kinetic Needling group were mostly like those before treatment(P>0.05).Compared with the Kinetic Needling group,the VAS scores after once treatment in the FSN group were significantly different(P<0.01).After two weeks of treatment,The VAS scores of two groups were significantly lower than those before and after one-time treatment(P<0.01).Compared with the Kinetic Needling group,the VAS scores after two-week treatment of the FSN group were significantly different(P<0.05).Therefore,it may infer that after two weeks of treatment,both the FSN group and the Kinetic Needling group can alleviate pain,and they both have great short-term effect.Furthermore,the FSN group has obvious advantages in pain relief,whose immediate and short-term effects are better than the Kinetic Needling group.2.Swelling score:There was not significant difference in swelling scores between two groups before treatment(P>0.05),indicating that two groups were comparable.After once treatment,the swelling scores of the FSN group and the Kinetic Needling group were mostly like those before treatment(P>0.05).Compared with the Kinetic Needling group,the swelling scores after once treatment in the FSN group were not significantly different(P>0.05).After two-week treatment,the swelling scores of two groups were both significantly lower than those before and after one-time treatment(P<0.01).Compared with the Kinetic Needling group,the swelling scores after two-week treatment of the FSN group were significantly different(P<0.01).It follows that both two groups have poor immediate effect in relieving edema,but after two weeks of treatment,both the FSN group and the Kinetic Needling group can effectively relieve edema,so two groups have good short-term effect.Furthermore,the FSN group has obvious advantages in relieving edema,which is better than the Kinetic Needling group.3.FMA score of upper limbs:There was no significant difference in FMA scores of upper limbs between two groups before treatment(P>0.05),indicating that two groups were comparable.After once treatment,the FMA scores of upper limbs in the FSN group and the Kinetic Needling group were mostly like those before treatment(P>0.05).Compared with the Kinetic Needling group,the FMA scores of upper limbs after once treatment in the FSN group were not significantly different(P>0.05).After two-week treatment,the FMA scores of upper limbs of two groups were both significantly higher than those before and after one-time treatment(P<0.01).Compared with the Kinetic Needling group,the FMA scores of upper limbs after two-week treatment of the FSN group were significantly different(P<0.05).Thus it can be seen both two groups have poor immediate effect in improving upper limb motor function,but after two-week treatment,both the FSN group and the Kinetic Needling group can improve upper limb motor function,so they both have great short-term effects.Furthermore,the FSN group has obvious advantages in improving upper limb motor function,which is better than the Kinetic Needling group.4.Comparison of clinical efficacy:After two weeks of treatment,5 cases were cured,16 cases were markedly effective,8 cases were effective,3 cases were ineffective,and the total effective rate of clinical efficacy reached 90.63%in the FSN group.As for the Kinetic Needling group,2 cases were cured,9 cases were markedly effective,13 cases were effective and 7 cases were ineffective,the total effective rate was 77.42%.Compared with the Kinetic Needling group,the clinical efficacy of the FSN group had significant difference(P<0.05).It Indicates that the two groups have great clinical efficacy after two-week treatment,and the FSN group is better than the Kinetic Needling group.ConclusionIt is found that both the FSN group and the Kinetic Needling group can effectively alleviate pain,relieve edema and improve upper limb motor function.Moreover,the short-term curative effect of the FSN group is better than the Kinetic Needling group in all aspects,and the immediate curative effect in relieving pain is also better than the Kinetic Needling group.At the same time,the clinical efficacy of the FSN group is better than the Kinetic Needling group.In brief,for treating patients with shoulder-hand syndrome phase I after stroke,this study shows that FSN is more dominant,worth to popularize in clinical and further in-depth study.